OTHER · Unmapped registry intervention
Prospective study assessments
Find medicine records ·
Find other trials using this name
Clinical trial
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06388421
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedDeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
United Therapeuticslead sponsor
Mapped research locations
PhiladelphiaPennsylvania, United States4New YorkNew York, United States2HoustonTexas, United States2DallasTexas, United States2ClevelandOhio, United States2PortlandOregon, United States2RichmondVirginia, United States2MilwaukeeWisconsin, United States2ChicagoIllinois, United States1Los AngelesCalifornia, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06388421 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.